BMC Medical Imaging (Nov 2024)

Computed tomography radiomics reveals prognostic value of immunophenotyping in laryngeal squamous cell carcinoma: a comparison of whole tumor- versus habitats-based approaches

  • Meng Qi,
  • Weiding Zhou,
  • Ying Yuan,
  • Yang Song,
  • Duo Zhang,
  • Jiliang Ren

DOI
https://doi.org/10.1186/s12880-024-01491-2
Journal volume & issue
Vol. 24, no. 1
pp. 1 – 12

Abstract

Read online

Abstract Background To compare the performance of whole tumor and habitats-based computed tomography (CT) radiomics for predicting immunophenotyping in laryngeal squamous cell carcinomas (LSCC) and further evaluate the stratified effect of the radiomics model on disease-free survival (DFS) and overall survival (OS) of LSCC patients. Methods In all, 106 LSCC patients (40 with inflamed and 66 with non-inflamed immunophenotyping) were randomly assigned into a training (n = 53) and testing (n = 53) cohort. Briefly, 750 radiomics features from contrast-enhanced CT images were respectively extracted from the whole tumor and two Otsu method-derived subregions. Intraclass correlation coefficients (ICCs) were calculated to evaluate the reproducibility. The radiomics models for predicting immunophenotyping were respectively created using K-nearest neighbors (KNN), logistic regression (LR), and Naive bayes (NB) classifiers. The performance of models in the testing cohort were compared using area under the curve (AUC). The prognostic value of the optimal model was determined by survival analysis. Results The radiomics features derived from whole tumor showed better reproducibility than those derived from habitats. The best model for the whole tumor (LR classifier) showed superior performance than that for the habitats (KNN classifier) in the testing cohort, but there were no significant differences (AUC: 0.741 vs. 0.611, p = 0.112). Multivariable Cox regression analysis showed that the immunophenotyping predicted by the optimal model was an independent risk factor of unfavorable DFS (p = 0.009) and OS (p = 0.008) in LSCC patients. Conclusions Whole tumor-based CT radiomics could serve as a potential predictive biomarker of immunophenotyping and outcome prediction in LSCC patients.

Keywords